Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Pediatr Blood Cancer. 2011 Sep 9;58(3):362–365. doi: 10.1002/pbc.23317

Figure 2.

Figure 2

Estimated proportion of patients who will not experience a CNS relapse following intrathecal topotecan administration according to time since starting treatment.